The Effects of Rs10754558 and Rs4612666 Polymorphisms on Preeclampsia Susceptibility, Onset, and Severity: a Case-control Study and in Silico Analysis

Overview

Journal Mol Biol Res Commun

Specialty Molecular Biology

Date 2024 Jun 25

PMID 38915451

Authors

Mahnaz Rezaei

Marzieh Ghasemi

Mohsen Saravani

Rahele Ghasemian- Moghadam

Hossein Shahraki-Ghadimi

Mahtab Norouzi

Saeedeh Salimi

Affiliations

Soon will be listed here.

Abstract

Preeclampsia (PE) is one of the serious complications of pregnancy and its exact etiology is unknown. Inflammasomes are multiportion complexes whose relation with PE has been described. Evidence showed the effect of NLRP3 inflammasome in PE pathogenesis. In the current study, we investigated the possible impacts of polymorphisms on PE. A total of 252 PE and 258 control pregnant women were selected for the study. The PCR-RFLP method was employed to genotype rs10754558 and rs4612666 polymorphisms. The RNAsnp and SpliceAid 2 software were used for in silico analysis. There was no relationship between polymorphisms and PE. In comparison to control women, the rs10754558 could increase the risk of severe PE in codominant and dominant models (OR=1.89, 95% CI=1.19-3.01, P=0.012, OR=1.95, 95% CI=1.24-3.06, P=0.0037, respectively). The findings of the in silico analysis revealed the effects of rs10754558 C to G and rs4612666 C to T substitutions on protein binding sites and rs10754558 C to G substitution on secondary RNA structure. These findings could confirm the finding those studies reported the impacts of these variants on various diseases. In conclusion, the rs10754558 variant was associated with an increased risk of EOPE and severe PE.

References

Chen A, Zhao H, Wang J, Zhang R, Liu J, Zhao X . Haplotype Analysis of Candidate Genes Involved in Inflammation and Oxidative Stress and the Susceptibility to Preeclampsia. J Immunol Res. 2020; 2020:4683798. PMC: 7061132. DOI: 10.1155/2020/4683798. View

Xu L, Li S, Liu Z, Jiang S, Wang J, Guo M . The NLRP3 rs10754558 polymorphism is a risk factor for preeclampsia in a Chinese Han population. J Matern Fetal Neonatal Med. 2018; 32(11):1792-1799. DOI: 10.1080/14767058.2017.1418313. View

Oiwa K, Watanabe S, Onodera K, Iguchi Y, Kinoshita Y, Komine O . Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis. Sci Adv. 2023; 9(31):eadf6895. PMC: 10403219. DOI: 10.1126/sciadv.adf6895. View

Zeng H, Han X, Zhu Z, Yu S, Mei S, Cheng X . Increased uterine NLRP3 inflammasome and leucocyte infiltration in a rat model of preeclampsia. Am J Reprod Immunol. 2021; 86(6):e13493. DOI: 10.1111/aji.13493. View

Goldberg E, Asher J, Molony R, Shaw A, Zeiss C, Wang C . β-Hydroxybutyrate Deactivates Neutrophil NLRP3 Inflammasome to Relieve Gout Flares. Cell Rep. 2017; 18(9):2077-2087. PMC: 5527297. DOI: 10.1016/j.celrep.2017.02.004. View

Chen-Plotkin A, Lee V, Trojanowski J . TAR DNA-binding protein 43 in neurodegenerative disease. Nat Rev Neurol. 2010; 6(4):211-20. PMC: 2892118. DOI: 10.1038/nrneurol.2010.18. View

Guo Q, Wu Y, Guo X, Cao L, Xu F, Zhao H . The RNA-Binding Protein CELF2 Inhibits Ovarian Cancer Progression by Stabilizing FAM198B. Mol Ther Nucleic Acids. 2020; 23:169-184. PMC: 7734233. DOI: 10.1016/j.omtn.2020.10.011. View

Gomez-Lopez N, Motomura K, Miller D, Garcia-Flores V, Galaz J, Romero R . Inflammasomes: Their Role in Normal and Complicated Pregnancies. J Immunol. 2019; 203(11):2757-2769. PMC: 6871659. DOI: 10.4049/jimmunol.1900901. View

Yoshino H, Enokida H, Chiyomaru T, Tatarano S, Hidaka H, Yamasaki T . Tumor suppressive microRNA-1 mediated novel apoptosis pathways through direct inhibition of splicing factor serine/arginine-rich 9 (SRSF9/SRp30c) in bladder cancer. Biochem Biophys Res Commun. 2011; 417(1):588-93. DOI: 10.1016/j.bbrc.2011.12.011. View

10.

Pontillo A, Reis E, Bricher P, Vianna P, Diniz S, Fernandes K . NLRP1 L155H Polymorphism is a Risk Factor for Preeclampsia Development. Am J Reprod Immunol. 2015; 73(6):577-81. DOI: 10.1111/aji.12353. View

11.

Kharaghani R, Cheraghi Z, Okhovat Esfahani B, Mohammadian Z, Nooreldinc R . Prevalence of Preeclampsia and Eclampsia in Iran. Arch Iran Med. 2015; 19(1):64-71. DOI: 0161901/AIM.0012. View

12.

Lee Y, Bae S . Association between functional NLRP3 polymorphisms and susceptibility to autoimmune and inflammatory diseases: a meta-analysis. Lupus. 2016; 25(14):1558-1566. DOI: 10.1177/0961203316644336. View

13.

Sutterwala F, Haasken S, Cassel S . Mechanism of NLRP3 inflammasome activation. Ann N Y Acad Sci. 2014; 1319:82-95. PMC: 4074217. DOI: 10.1111/nyas.12458. View

14.

Lee Y, Song G . The role of NLRP3 and CARD8 polymorphisms in the risk of rheumatoid arthritis: A meta-analysis of genetic association studies. Int J Rheum Dis. 2023; 26(11):2214-2222. DOI: 10.1111/1756-185X.14917. View

15.

Barreau C, Paillard L, Mereau A, Osborne H . Mammalian CELF/Bruno-like RNA-binding proteins: molecular characteristics and biological functions. Biochimie. 2006; 88(5):515-25. DOI: 10.1016/j.biochi.2005.10.011. View

16.

Rezaei M, Eskandari F, Mohammadpour-Gharehbagh A, Teimoori B, Yaghmaei M, Mokhtari M . The Drosha rs10719 T>C polymorphism is associated with preeclampsia susceptibility. Clin Exp Hypertens. 2017; 40(5):440-445. DOI: 10.1080/10641963.2017.1392555. View

17.

Cheng L, Yin R, Yang S, Pan X, Ma A . Rs4612666 Polymorphism of the NLRP3 Gene Is Associated with the Occurrence of Large Artery Atherosclerotic Ischemic Strokes and Microembolic Signals. Biomed Res Int. 2018; 2018:6345805. PMC: 5937605. DOI: 10.1155/2018/6345805. View

18.

Shirasuna K, Karasawa T, Takahashi M . Role of the NLRP3 Inflammasome in Preeclampsia. Front Endocrinol (Lausanne). 2020; 11:80. PMC: 7053284. DOI: 10.3389/fendo.2020.00080. View

19.

Hod T, Cerdeira A, Karumanchi S . Molecular Mechanisms of Preeclampsia. Cold Spring Harb Perspect Med. 2015; 5(10). PMC: 4588136. DOI: 10.1101/cshperspect.a023473. View

20.

Zhang Y, Yang W, Li W, Zhao Y . NLRP3 Inflammasome: Checkpoint Connecting Innate and Adaptive Immunity in Autoimmune Diseases. Front Immunol. 2021; 12:732933. PMC: 8542789. DOI: 10.3389/fimmu.2021.732933. View